These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22517503)

  • 21. Prevention of colorectal cancer in inflammatory bowel disease: value of screening and 5-aminosalicylates.
    Munkholm P; Loftus EV; Reinacher-Schick A; Kornbluth A; Mittmann U; Esendal B
    Digestion; 2006; 73(1):11-9. PubMed ID: 16410688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy-Induced Intestinal Mucosal Barrier Damage: a Cause of Falsely Elevated Serum 1,3-Beta-d-Glucan Levels?
    Prattes J; Raggam RB; Vanstraelen K; Rabensteiner J; Hoegenauer C; Krause R; Prüller F; Wölfler A; Spriet I; Hoenigl M
    J Clin Microbiol; 2016 Mar; 54(3):798-801. PubMed ID: 26719433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic review: histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative.
    Bryant RV; Winer S; Travis SP; Riddell RH
    J Crohns Colitis; 2014 Dec; 8(12):1582-97. PubMed ID: 25267173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucosal Healing and Deep Remission: A New Treatment Paradigm for Inflammatory Bowel Disease.
    Thomas A; Lodhia N
    J S C Med Assoc; 2015 Jan; 110(4):134-5. PubMed ID: 27141694
    [No Abstract]   [Full Text] [Related]  

  • 25. Biomarkers and non-invasive tests for gastrointestinal mucositis.
    Kuiken NSS; Rings EHHM; Blijlevens NMA; Tissing WJE
    Support Care Cancer; 2017 Sep; 25(9):2933-2941. PubMed ID: 28536886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cancer risk in inflammatory bowel disease].
    Gallo Reynoso S
    Rev Gastroenterol Mex; 1996; 61(4 Suppl 2):S51-3. PubMed ID: 9102779
    [No Abstract]   [Full Text] [Related]  

  • 27. Endoscopic and Histologic Healing in Children With Inflammatory Bowel Diseases Treated With Thalidomide.
    Lazzerini M; Villanacci V; Pellegrin MC; Martelossi S; Magazzù G; Pellegrino S; Lucanto MC; Barabino A; Calvi A; Arrigo S; Lionetti P; Fontana M; Zuin G; Maggiore G; Bramuzzo M; Maschio M; Salemme M; Manenti S; Lorenzi L; Decorti G; Montico M; Ventura A
    Clin Gastroenterol Hepatol; 2017 Sep; 15(9):1382-1389.e1. PubMed ID: 28286192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fecal calprotectin as a marker of the severity of mucosal inflammation in children with inflammatory bowel disease.
    Dolinšek J; Rižnik P; Sabath L; Mičetić-Turk D
    Wien Klin Wochenschr; 2016 Apr; 128(7-8):253-9. PubMed ID: 26659704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease.
    Peyrin-Biroulet L; Ferrante M; Magro F; Campbell S; Franchimont D; Fidder H; Strid H; Ardizzone S; Veereman-Wauters G; Chevaux JB; Allez M; Danese S; Sturm A;
    J Crohns Colitis; 2011 Oct; 5(5):477-83. PubMed ID: 21939925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of treatment-induced mucosal barrier injury.
    Blijlevens NM
    Curr Opin Oncol; 2005 Nov; 17(6):605-10. PubMed ID: 16224241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.
    Guidi L; Marzo M; Andrisani G; Felice C; Pugliese D; Mocci G; Nardone O; De Vitis I; Papa A; Rapaccini G; Forni F; Armuzzi A
    Dig Liver Dis; 2014 Nov; 46(11):974-9. PubMed ID: 25096964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.
    Bjarnason I; Hayee B; Pavlidis P; Kvasnovsky C; Scalori A; Sisson G; Charlesworth A; Shaikh H; Bjornsson E; Heneghan MA
    EBioMedicine; 2015 Oct; 2(10):1523-7. PubMed ID: 26629548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality bowel preparation for surveillance colonoscopy in patients with inflammatory bowel disease is a must.
    Nett A; Velayos F; McQuaid K
    Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):379-92. PubMed ID: 24975529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
    Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G
    World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory Bowel Disease and Immune Thrombocytopenic Purpura: Combined Immune Dysregulation in an Adolescent.
    Queliza K; Ihekweazu FD; Ali A; Kellermayer R
    Ann Clin Lab Sci; 2017 Mar; 47(2):226-228. PubMed ID: 28442528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.
    Chang J; Leong RW; Wasinger VC; Ip M; Yang M; Phan TG
    Gastroenterology; 2017 Sep; 153(3):723-731.e1. PubMed ID: 28601482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disease activity assessment in IBD: clinical indices and biomarkers fail to predict endoscopic remission.
    Falvey JD; Hoskin T; Meijer B; Ashcroft A; Walmsley R; Day AS; Gearry RB
    Inflamm Bowel Dis; 2015 Apr; 21(4):824-31. PubMed ID: 25738372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alimentary tract mucositis in cancer patients: impact of terminology and assessment on research and clinical practice.
    Peterson DE; Keefe DM; Hutchins RD; Schubert MM
    Support Care Cancer; 2006 Jun; 14(6):499-504. PubMed ID: 16775646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Endoscopic scoring in management of inflammatory bowel diseases].
    Prieux-Klotz C; Abitbol V
    Presse Med; 2017 Apr; 46(4):374-380. PubMed ID: 28126504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Giant inflammatory polyposis as the first manifestation of inflammatory bowel disease.
    Biondi A; Persiani R; Paliani G; Mattana C; Vecchio FM; D'Ugo D
    Am J Gastroenterol; 2009 Sep; 104(9):2359-60. PubMed ID: 19727099
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.